Abstract
Mallinckrodt, a business unit of Tyco Healthcare, is an industry leader in
imaging. This report provides a full review of the company' s medical imaging
activities.
Mallinckrodt, a business of Tyco Healthcare, is headquartered in St. Louis,
Missouri and is an industry leader in imaging, providing contrast media and
delivery systems, radiopharmaceuticals and urology imaging systems.
Mallinckrodt' s respiratory operations are now covered by Tyco' s Nellcor and
Puritan Bennett subsidiaries.
Mallinckrodt Imaging' s products can be used for many imaging procedures,
including CT, MRI, ultrasound, X-ray, urology and nuclear medicine. The
company holds the third-largest share of the global market for contrast agents
after GE Healthcare and Schering, and the second-largest market share after GE
for nuclear medicine contrast media.
This company report provides
Executive Summary
An overview of the company, including operating activities, at a glance key
events and strategic focus.
Product Portfolio and R&D
The product section of the report focuses on the key aspects of the company' s
portfolio and technology, covering core products, key brands, new products and
analysis of the competition. Sales data, market size and future potential is
included where available.
International Activities
The company' s business activities by geographic region and country.
Appendices
- Key corporate events
- Mergers & acquisitions
- Divestitures
- Agreements
This report is also available as an integral part of the Tyco Healthcare
Company Intelligence Report. Tyco Healthcare is one of the world' s largest
healthcare companies, offering surgical tools and supplies, sutures and wound
care, needles and syringes, contrast media for diagnostic imaging, vascular
therapy, respiratory care and generic pharmaceuticals. Click here for more
information.
View Cart
